about
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Ico...
Read More
108.77
1.61
(1.50%)
101.0K
XNAS Volume
XNAS 08 Apr, 2026 10:41 AM (EDT)
Not Eligible
Mid Valuation
Technically Bearish
Icon PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..